The PillCam™ capsule endoscopy platform provides clear images([FOOTNOTE=User Manual (DOC-2044-02 March 2013), page 8.],[ANCHOR=],[LINK=]) and allows for the visualization of the esophagus, stomach, duodenum, small bowel, and colonic mucosa.([FOOTNOTE=User Manual (DOC-2044-02 March 2013), page 103],[ANCHOR=],[LINK=]) This platform enables physicians to detect chronic diseases, visualize disease activity, and assess treatment efficacy.([FOOTNOTE=User Manual (DOC-2044-02 March 2013), pages 3, 123.],[ANCHOR=],[LINK=])
Support early detection of gastrointestinal diseases and functional disorders with a complete portfolio of motility testing products. Medtronic offers esophageal manometry, anorectal manometry, and capsule-based motility testing, enabling you to do full evaluations of GI tract motor function to understand the root cause of GI functional disorders.([FOOTNOTE=Kahrilas PJ. Esophageal motor disorders in terms of high-resolution esophageal pressure topography: what has changed? Am J Gastroenterol. 2010;105:981-7.],[ANCHOR=],[LINK=]),([FOOTNOTE=Conklin J. Color Atlas of High Resolution Manometry. Springer Publishing. 2009. Page 71.],[ANCHOR=],[LINK=]),([FOOTNOTE=Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014;109:1141-57.],[ANCHOR=],[LINK=]),([FOOTNOTE=Carrington EV, Brokjaer A, Craven H, Zarate N, Horrocks EJ, Palit S, et al. Traditional measures of normal anal sphincter function using high-resolution anorectal manometry (HRAM) in 115 healthy volunteers. Neurogastroenterol Motil. 2014;26(5):625-35.],[ANCHOR=],[LINK=])
The Beacon™ EUS delivery system is designed for consistent tissue sample acquisition with intact cell architecture([FOOTNOTE=DDW 2015 Presentations: #935. A Novel EUS-guided Liver Biopsy Needle is Superior to 19-G Core and FNA Needles: Examining the Effect of Needle Design, Number of Excursions, and Variable Suction Parameters on Histologic Yield. Schulman A, Thompson C, Chan W, Ryou M. #Tu1638. Initial experience with a novel EUS-guided core biopsy needle (SharkCore™): a North American multicenter study. DiMaio C, Kolb J , Benias P, et al. #Tu1648. Evaluating The Efficacy of a New FDA Approved EUS Core Biopsy Needle and Different Fine Needle Biopsy (FNB) Techniques To Yield The best Core Specimen In a Live Porcine Model. Shivangi Kothari S, Kothari T, Zhou Z, et al.],[ANCHOR=],[LINK=]),([FOOTNOTE=Based on product development testing data. Data on file. (See Report #1085 and Report #1090).],[ANCHOR=],[LINK=]) and enables fast needle exchange without changing scope position, resulting in reduced procedural time.([FOOTNOTE=Enestvedt B, Maranki, J, Makipour K, Mathur M, Haluszka O. Is two better than one? A comparison of EUS-FNA efficiency of single- vs multi-needle platforms. Gastrointestinal Endoscopy. 2013;77(5S):AB179.],[ANCHOR=],[LINK=]) This innovative system supports early detection that leads to early treatment of GI diseases by improving diagnostic capabilities and helping physicians meet each patient’s individual needs.
Our reflux service line provides actionable information for timely treatment decisions.1-6 These reflux testing products feature both capsule-based and catheter-based technologies, giving physicians the flexibility to offer solutions that best meet their patients' needs.
The Barrx™ radiofrequency ablation system has been proven more effective than surveillance in reducing the risk of disease progression in patients with Barrett’s esophagus.11,12,([FOOTNOTE=Das A, Wells C, Kim HJ, Fleischer DE, Crowell MD, Sharma VK. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett’s esophagus. Endoscopy. 2009;41:400-8.],[ANCHOR=],[LINK=]) In fact, patients with confirmed low-grade dysplasia experienced a 94% reduction in relative risk of progression to high-grade dysplasia or esophageal cancer.12